India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Subscribe To Our Newsletter & Stay Updated
